Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease
about
sameAs
In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factorA critical appraisal of the phenomenon of aspirin resistanceAspirin resistanceAspirin and clopidogrel resistance: an emerging clinical entityThromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?Aspirin resistance: Fact or fiction? A point of view.Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Thrombosis, physical activity, and acute coronary syndromes.Thrombelastography: current clinical applications and its potential role in interventional cardiology.Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery diseaseAspirin and clopidogrel response variability: review of the published literaturePharmacogenomics of platelet responsiveness to aspirin.Aspirin resistance: biological and clinical implications.Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart diseaseAspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.High on-treatment platelet reactivity: risk factors and 5-year outcomes in patients with acute myocardial infarction.Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.Antiplatelet therapy and vascular disease: an update.Antiplatelet treatment in the primary prophylaxis of cardiovascular disease in patients with arterial hypertension.Effect of exercise on platelet activation during aspirin or clopidogrel intake in healthy men.[Acetylsalicylic acid non-responders after ischemic insult in geriatric patients].Relationship between endothelial functions and acetylsalicylic acid resistance in newly diagnosed hypertensive patients.
P2860
Q28166489-B27C00C7-711C-4AB4-B8EE-8260D03E733DQ28183919-D2E6563B-41E0-4EC4-BB07-B65A41A85EAAQ28187611-AD22251D-A84F-4F5D-9EC4-6E5A35D6851EQ28194021-135E02BA-B391-4CE4-ADD6-14D3F51EE763Q28200486-A8405C1A-009A-49CD-9BC1-C1A225913324Q34389630-7B34F198-8EDB-4C74-BD4E-592E9282787AQ34771381-9F241828-FD2E-4BC5-958D-12796ACE441BQ35159981-82AFB2EC-9AFE-453D-878C-4FCE1E23FB54Q36664802-5B4EA99D-6844-464E-BE08-704E988D96BEQ36769860-55D7CBE1-3DF3-40CF-8A75-E1AC70F06EF6Q36932221-5D4AABCB-2B3B-4F23-AB29-D3F5A90D99A8Q36989841-52D7DD9D-5646-40F2-B5B3-CAEAA3BCD048Q37089560-F004704C-469F-42FA-A593-A847AFB44F48Q37248584-FEA21C52-2DF2-4C3D-8B31-4F984F7D6D99Q37458916-0AB98317-8AD1-4B41-8F56-1D144AD732EEQ37680302-FD9A502C-8D32-4913-8451-7C589E1E8F45Q37752222-9BBF8745-F5BE-43FB-8D9E-279E09F3BCA8Q37838100-B1B0CA6C-64D1-4EAB-8106-B2792235F5E2Q41076435-C84FFF0A-02B7-474F-A18F-BA7CAC2310B8Q42167779-794913A8-8E52-4FAB-8037-55101E392837Q52881694-0A6B2254-B7A0-4B2B-9A06-C74D85CFF5B0Q53103471-96FAAC10-61FF-4632-A7BD-F8171703AB71
P2860
Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Resistance to aspirin in vitro ...... proven coronary artery disease
@ast
Resistance to aspirin in vitro ...... proven coronary artery disease
@en
Resistance to aspirin in vitro ...... proven coronary artery disease
@nl
type
label
Resistance to aspirin in vitro ...... proven coronary artery disease
@ast
Resistance to aspirin in vitro ...... proven coronary artery disease
@en
Resistance to aspirin in vitro ...... proven coronary artery disease
@nl
prefLabel
Resistance to aspirin in vitro ...... proven coronary artery disease
@ast
Resistance to aspirin in vitro ...... proven coronary artery disease
@en
Resistance to aspirin in vitro ...... proven coronary artery disease
@nl
P2093
P1433
P1476
Resistance to aspirin in vitro ...... proven coronary artery disease
@en
P2093
C Duplantier
L Christiaens
P356
10.1016/S0049-3848(03)00008-2
P407
P577
2002-11-01T00:00:00Z